Cascinu, S., Berardi, R., Salvagni, S., Beretta, G. D., Catalano, V., Pucci, F., . . . Ardizzoni, A. (2008). A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation. Nature Publishing Group.
Styl ChicagoCascinu, S., et al. A Combination of Gefitinib and FOLFOX-4 As First-line Treatment in Advanced Colorectal Cancer Patients. A GISCAD Multicentre Phase II Study Including a Biological Analysis of EGFR Overexpression, Amplification and NF-kB Activation. Nature Publishing Group, 2008.
Citace podle MLACascinu, S., et al. A Combination of Gefitinib and FOLFOX-4 As First-line Treatment in Advanced Colorectal Cancer Patients. A GISCAD Multicentre Phase II Study Including a Biological Analysis of EGFR Overexpression, Amplification and NF-kB Activation. Nature Publishing Group, 2008.